Loading live market data…

Companhia de Saneamento Básico do Estado de São Paulo - SABESP

NYSE:SBS

$5.92 USD

-$0.05 (-0.84%)

Volume
5.25M
Average Volume
6.62M
Market Capitalization
$20.23B
P/E Ratio
2.80
Dividend Yield
2.32%
Price Target
$23.79
Year High
$7.16
Year Low
$3.78
Day High
Day Low
Payout Ratio
$0.27
Current Ratio
$1.74
Source Headline
SBS or AWR: Which Is the Better Value Stock Right Now?

Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com - 2026-07-06 12:40:27

Does Sabesp (SBS) Have the Potential to Rally 25.04% as Wall Street Analysts Expect?

The mean of analysts' price targets for Sabesp (SBS) points to a 25% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

zacks.com - 2026-06-26 10:57:12

SBS vs. AWR: Which Stock Is the Better Value Option?

Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-06-17 12:40:31

All You Need to Know About Sabesp (SBS) Rating Upgrade to Buy

Sabesp (SBS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com - 2026-06-09 13:01:14

SBS or AWR: Which Is the Better Value Stock Right Now?

Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-06-01 12:41:06

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog) PR Newswire SEOUL, South Korea, May

gurufocus.com - 2026-06-01 00:00:00

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp Q1 Earnings Call Highlights

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp NYSE: SBS reported higher first-quarter 2026 revenue, EBITDA and net income, while management said the company continued to accelerate investments tied to its universal access commitments and operational transformation.

marketbeat.com - 2026-05-15 04:12:29

SBS vs. AWR: Which Stock Is the Better Value Option?

Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-05-14 12:41:12

4 Stocks to Watch From the Challenging Water Supply Industry

Water utilities like SBS, AWR, AWK and CWT are supported by strategic capital investment plans and strong customer bases, positioning them to outperform peers despite persistent challenges facing the water industry.

zacks.com - 2026-05-12 12:16:35

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-11 20:00:47

Stratec Q1 Earnings Call Highlights

Stratec ETR: SBS reported a soft start to fiscal 2026, with first-quarter revenue and adjusted earnings down from the prior-year period, but management reaffirmed its full-year guidance and said visibility into second-half demand has improved.

marketbeat.com - 2026-05-11 09:07:35

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the company will present data from its LANDMARK survey during the 2026 Digestive Disease Week® (DDW) meeting being held from May 2-5 in Chicago, IL. The data will spotlight healthcare professional (HCP) insights on the burden of total parenteral nutrition (TPN) f.

businesswire.com - 2026-04-23 07:05:00

Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments

LONDON, NEW YORK & LISBON, Portugal--(BUSINESS WIRE)-- #LegalTech--Stella Legal and SBS unite to launch a tech-first operating model. It optimizes in-house legal departments via data-driven "Performance Intelligence.".

businesswire.com - 2026-04-22 09:03:00

Companhia de saneamento Basico Do Estado De Sao Paulo – Sabesp $SBS Shares Purchased by Assetmark Inc.

Assetmark Inc. increased its stake in shares of Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE: SBS) by 3.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 985,400 shares of the utilities provider's stock

defenseworld.net - 2026-04-16 03:26:25

Get SBS Insider Trade Alerts

SBS Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$23.79

1 analysts

SBS Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2019-11-14 Goldman Sachs Maintain Neutral Neutral
2018-05-18 Goldman Sachs Downgrade Buy Neutral
2018-03-12 Janney Capital Downgrade Buy Neutral
2018-03-12 Janney Montgomery Scott Downgrade Buy Neutral
2017-11-27 JP Morgan Upgrade Neutral Overweight
2017-11-22 HSBC Upgrade Hold Buy
2017-08-14 Citigroup Downgrade Neutral Sell
2017-03-06 Standpoint Research Downgrade Buy Hold
2016-08-03 Janney Montgomery Scott Downgrade Buy Neutral
2016-08-03 Janney Capital Downgrade Buy Neutral